Zobrazeno 1 - 10
of 808
pro vyhledávání: '"M, Blombäck"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Medica Scandinavica. 212:195-200
A comprehensive survey of the Swedish hemophilic population (hemophilia A and B) was undertaken in 1980. The total number of known hemophiliacs was 564. The ratio of hemophilia A to B was 4:1. The severe form constituted about 30% of each type. The i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3ac44d95539f9ae5467cfa2affbcf80
https://doi.org/10.1111/j.0954-6820.1982.tb03200.x
https://doi.org/10.1111/j.0954-6820.1982.tb03200.x
Publikováno v:
Scandinavian Journal of Haematology. 33:379-382
T cell subpopulations were determined in 88 Swedish patients with severe hemostatic disorders treated with domestic or imported American factor VIII or Swedish factor IX preparations at two centres, Karolinska hospital (KH) and Malmo hospital (MH). A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d20119d03bc12a41fe8cbe4e83c14033
https://doi.org/10.1111/j.1600-0609.1984.tb02590.x
https://doi.org/10.1111/j.1600-0609.1984.tb02590.x
Publikováno v:
Clinical & Laboratory Haematology. 23:313-316
Antithrombin (AT) is a glycoprotein mainly synthesised in the liver, and is one of the most important inhibitors of coagulation. Although AT activity determination is more important in clinical practice and anti-IIa and anti-Xa chromogenic tests are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7121efbc83236ebfdf3c55a77c0d83dd
https://doi.org/10.1046/j.1365-2257.2001.00410.x
https://doi.org/10.1046/j.1365-2257.2001.00410.x
Autor:
D. Ginsburg, P. M. Mannucci, L. Vermylen, M. Blombäck, C Petersson, I. R. Peake, J. J. Michiels, Stefan Lethagen, R. Nuss, Christian Freiburghaus, Lilian Tengborn, Rolf Ljung, F. Giannelli, C. Rodriguez-Merchan, Björn Dahlbäck, Erik Berntorp, L. Hoyer, Lars Holmberg, Jan Astermark, L. Aledort, H. Petersson, G. Mariani
Publikováno v:
Haemophilia. 7:401-410
Professor Inga Marie Nilsson (1923-99) was a pioneer in the field of bleeding and thrombo-embolic disorders and made several major scientific contributions during her career. To honour her memory, colleagues from all over the world were invited to co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f8c7471f8d47d87ba03013d0cf61fda
https://doi.org/10.1111/j.1365-2516.2001.00524.x
https://doi.org/10.1111/j.1365-2516.2001.00524.x
Publikováno v:
Fibrinolysis and Proteolysis. 13:163-167
Objective: As the relationship between increased fibrinogen levels, including that in smokers, and cardiovascular complications is not fully understood we investigated the fibrin gel structure in a group of smokers and non-smokers. Design: Fibrin gel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a6e1c153b0d0d303ddcab12c8affa04
https://doi.org/10.1016/s0268-9499(99)90067-x
https://doi.org/10.1016/s0268-9499(99)90067-x
Publikováno v:
Blood Coagulation & Fibrinolysis. 10:127-132
Published reports do not agree about whether protein C activity is non-significantly changed or decreased in a hypercoagulable state induced by pre-eclampsia without hemolysis-elevated liver enzyme/low platelet (HELLP) syndrome. In order to assess th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9a21f204e3b736c41ad81d74e2eaaa
https://doi.org/10.1097/00001721-199904000-00003
https://doi.org/10.1097/00001721-199904000-00003
Publikováno v:
Fibrinolysis and Proteolysis. 12:360-365
Summary Objective: To investigate if treatment with a low daily dose of acetylsalicylic acid (ASA) may increase fibrin gel porosity in patients with diabetes mellitus. Design: A pilot-study. Setting: Out-patient clinic, Department of Endocrinology an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5d1c2beb901df9dc3348aa3a86d31ca
https://doi.org/10.1016/s0268-9499(98)80394-9
https://doi.org/10.1016/s0268-9499(98)80394-9
Publikováno v:
Journal of Internal Medicine. 242:115-119
von Willebrand's disease (vWD) is caused by qualitative (type 2) and quantitative (types 1 and 3) abnormalities of von Willebrand factor (vWF). vWD type 3, a severe form of the disease with nearly complete deficiency of the protein in plasma, are fou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f42afd81a0c0986832ce7ff7624b153
https://doi.org/10.1111/joim.1997.242.s740.115
https://doi.org/10.1111/joim.1997.242.s740.115
Publikováno v:
Pure and Applied Chemistry. 69:1043-1080
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bad3ca5058c03b2cfa5f9871fab32633
https://doi.org/10.1351/pac199769051043
https://doi.org/10.1351/pac199769051043